This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Antibody Remove Genetic Engineering Remove Insulin Related Topics
In-Vivo In-Vitro Life Science Genetics Protein Immune Response Pharma Companies Vaccine Vaccination Containment More Related Topics >
article thumbnail

Scottish drug discovery: advancing new research models

Drug Discovery World

MAY 25, 2023

Advances like genetically engineered mouse models (GEMMs), patient-derived xenografts (PDXs) and organoids are allowing the integration of mouse models with human cohorts. Research has shown that metabolism + inflammation leads to insulin resistance in type 2 diabetes.

Research 52
Research Drugs In-Vitro Insulin 52
article thumbnail

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

XTalks

AUGUST 17, 2020

This typically involves taking T cells from the body, engineering chimeric receptor antigens (CAR) and inserting them into the cells, expanding the cells ex vivo and injecting them back into the body. Monoclonal antibodies : these are antibodies that are designed to bind to specific targets on cells. Image from Cue Biopharma.

Protein 98
Protein Engineer Immune Response In-Vivo 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024